Immucell (ICCC) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Immucell Corporation  (NASDAQ: ICCC)


Immucell's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Immucell's ROA in the second quarter of 2026?
Immucell Corporation achieved a return on average assets (ROA) of 1.71 % in its second quarter of 2026, this is above ICCC's average return on assets of -1.79%.
Immucell Corporation assets over the 12 months ending in its second quarter of 2026 are valued at $46 million

Despite the company's net income deteriorating, Immucell was able to improve its ROA compared to the first quarter of 2026.

However, within the Healthcare sector 194 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2691, from total ROA ranking in the first quarter of 2026 at 3244.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -0.2 % -3.32 % 5.23 % 2.88 % 11.62 %
Y / Y Net Income Change 265.56 % 34.18 % - - -
Net Income (TTM) in million 1 -1 -1 2 2
Return On Assets (TTM) 1.71 % -1.19 % -2.24 % 5.07 % 3.87 %
ICCC's Total Ranking # 2691 # 3244 # 1163 # 1367 # 2689
Total Assets (TTM) in million 47 44 47 46 47
Seq. Total Assets Change 5.72 % -7.06 % 3.78 % -2.12 % 2.41 %
Seq. Net Income Change -5.51 % - - - -65.32 %

ICCC's 5 Years Annual ROA >> Back to ICCC Management Effectiveness >> Compare ICCC ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 2
Sector # 195
Overall # 1877

Return On Assets Statistics
High Average Low
9.46 %
-1.79 %
-14.28 %
(Dec 31 2015)   (Sep 30 2023)





Financial Statements
Immucell's Assets $ 47 million ICCC's Balance sheet
Immucell's Income $ 2 million Quarterly ICCC's Income Statement
ICCC's Income by Division See ICCC's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -5.69 % -34.39 % 53.22 % 0.89 % 10.2 %
Total Assets in million 43 45 69 45 44
Y / Y Net Income Change - - - - -
Net Income in million -1 -2 -6 -2 0
Annual Return On Assets -2.45 % -4.78 % -8.4 % -5.56 % -0.18 %

ICCC's 5 Years Annual ROA >> Back to ICCC Management Effectiveness >> Compare ICCC ROA to its Competitors



More Return On Assets Ratios
ICCC's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ICCC's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ICCC's Competitors
Subscribers only: Roa for Immucell's Suppliers
Subscribers only: Return On Assets for ICCC's Customers

You may also want to know
ICCC's Roi ICCC's Inventory Turnover Ratio ICCC's Growth Rates ICCC's Dividend Comparisons
ICCC's Profitability Ratios ICCC's Asset Turnover Ratio ICCC's Dividend Growth
ICCC's Roe ICCC's Valuation Ratios ICCC's Financial Strength Ratios ICCC's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Amphastar Pharmaceuticals Inc   4.70 %
Abbvie Inc   4.68 %
The Cooper Companies Inc   4.57 %
IMPACT BIOMEDICAL INC.  4.47 %
Nrc Health  4.31 %
Cadre Holdings inc   4.29 %
The Pennant Group Inc   4.14 %
U S Physical Therapy Inc  4.08 %
Haemonetics Corporation  3.99 %
Henry Schein Inc   3.79 %
Integer Holdings Corporation  3.76 %
Zimmer Biomet Holdings Inc   3.51 %
Ardent Health Inc   3.22 %
Community Health Systems Inc   3.17 %
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %
Merck and Co Inc   2.42 %
Privia Health Group Inc   2.41 %
Lifestance Health Group Inc   2.33 %
Bio rad Laboratories Inc   2.21 %
Pfizer Inc  2.12 %
Mimedx Group Inc   1.99 %
Revvity Inc  1.97 %
Alkermes Plc   1.96 %
Becton Dickinson And Company  1.77 %
Teva Pharmaceutical Industries Limited  1.77 %
Immucell Corporation  1.76 %
Envista Holdings Corporation  1.69 %

Date modified: 2026-09-26T06:50:52+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.